News about Global Pharma

Eton Pharmaceuticals Secures US FDA Approval for KHINDIVI Oral Solution

Eton Pharmaceuticals Secures US FDA Approval for KHINDIVI Oral Solution

Eton Pharmaceuticals has received FDA approval for KHINDIVI, the first and only oral hydrocortisone solution for paediatric patients aged 5 and older with adrenocortical insufficiency, offering precise, ready-to-use dosing without the need for tablet splitting.

Global Pharma | 31/05/2025 | By Manvi 388

Terumo Launches ROADSAVER Carotid Stent System for Commercial Use

Terumo Launches ROADSAVER Carotid Stent System for Commercial Use

Terumo Interventional Systems (TIS), a division of Terumo Corporation, announces the early commercial availability of its FDA-approved ROADSAVER™ Carotid Stent System. Indicated for use with the Nanoparasol® Embolic Protection System, ROADSAVER Stent System addresses carotid artery stenosis in patients with increased risk of adverse events

Global Pharma | 28/05/2025 | By Manvi 352

Olympus Receives FDA Clearance for EZ1500 Endoscopes with EDOF Technology

Olympus Receives FDA Clearance for EZ1500 Endoscopes with EDOF Technology

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced FDA 510(k) clearance of its EZ1500 series endoscopes featuring Extended Depth of Field (EDOF™) technology.

Global Pharma | 28/05/2025 | By Manvi 383

Sandoz Introduces Pyzchiva Autoinjector, First Commercially Available in Europe for Ustekinumab Biosimilars

Sandoz Introduces Pyzchiva Autoinjector, First Commercially Available in Europe for Ustekinumab Biosimilars

Sandoz has launched Pyzchiva, the first ustekinumab biosimilar autoinjector in Europe, aiming to enhance patient comfort and adherence in the treatment of chronic inflammatory diseases.

Global Pharma | 27/05/2025 | By Manvi 272

Unicon Pharma Partners with VRR Life Sciences to Expand Global CSV Capabilities

Unicon Pharma Partners with VRR Life Sciences to Expand Global CSV Capabilities

Unicon Pharma has partnered with Bengaluru-based VRR Life Sciences to expand global computer system validation (CSV) services and drive digital transformation in the life sciences industry.

Global Pharma | 27/05/2025 | By Manvi 432

Zylox-Tonbridge Secures First International Approval for Vascular Device in Indonesia

Zylox-Tonbridge Secures First International Approval for Vascular Device in Indonesia

Zylox-Tonbridge Medical Technology Co., Ltd. announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval in Indonesia. This marks the ZYLOX Unicorn™ Vascular Closure Device's first international market clearance and the Company's first market authorization in Southeast Asia.

Global Pharma | 27/05/2025 | By Manvi 200

Delta Development's Blood Coolers Set New Standard for Prehospital Care Across US

Delta Development's Blood Coolers Set New Standard for Prehospital Care Across US

Delta Development Team (DDT) announce that its innovative APRU 6L portable blood refrigerator and Delta ICE 2L Smart Blood Cooler are setting a national benchmark for prehospital blood storage and transport, revolutionizing healthcare on both the West and East coasts, helping emergency services deliver life-saving care from California to New Jersey.

Global Pharma | 27/05/2025 | By Manvi 160

Mindray Launches BeneVision V Series at Euroanaesthesia 2025 in Lisbon

Mindray Launches BeneVision V Series at Euroanaesthesia 2025 in Lisbon

Mindray launched its BeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon.

Global Pharma | 26/05/2025 | By Manvi 394

Esaote Debuts MyLabHeron Ultrasound at SCIVAC Congress in Rimini

Esaote Debuts MyLabHeron Ultrasound at SCIVAC Congress in Rimini

MyLab™Heron is the latest result of Esaote's research activity in high-performance portable ultrasound systems, in which the Company has now been recognized for over 30 years and where it stands out for its comprehensive product portfolio and innovative solutions.

Global Pharma | 26/05/2025 | By Manvi 116

Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011

Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011

US Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation to RLF-TD011 for the treatment of epidermolysis bullosa (EB).

Global Pharma | 26/05/2025 | By Manvi 192

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members